158 related articles for article (PubMed ID: 16628264)
1. Retinoic acid receptor-related orphan receptor alpha as a therapeutic target in the treatment of dyslipidemia and atherosclerosis.
Jakel H; Fruchart-Najib J; Fruchart JC
Drug News Perspect; 2006 Mar; 19(2):91-7. PubMed ID: 16628264
[TBL] [Abstract][Full Text] [Related]
2. The "CholesteROR" protective pathway in the vascular system.
Boukhtouche F; Mariani J; Tedgui A
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):637-43. PubMed ID: 14751813
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling.
Kim EJ; Yoo YG; Yang WK; Lim YS; Na TY; Lee IK; Lee MO
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1796-802. PubMed ID: 18658046
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid receptor-related orphan receptor alpha regulates a subset of cone genes during mouse retinal development.
Fujieda H; Bremner R; Mears AJ; Sasaki H
J Neurochem; 2009 Jan; 108(1):91-101. PubMed ID: 19014374
[TBL] [Abstract][Full Text] [Related]
5. Retinoid-related orphan receptor alpha and the regulation of lipid homeostasis.
Fitzsimmons RL; Lau P; Muscat GE
J Steroid Biochem Mol Biol; 2012 Jul; 130(3-5):159-68. PubMed ID: 21723946
[TBL] [Abstract][Full Text] [Related]
6. A promoter element with enhancer properties, and the orphan nuclear receptor RORalpha, are required for Purkinje cell-specific expression of a Gi/o modulator.
Serinagaoglu Y; Zhang R; Zhang Y; Zhang L; Hartt G; Young AP; Oberdick J
Mol Cell Neurosci; 2007 Mar; 34(3):324-42. PubMed ID: 17215137
[TBL] [Abstract][Full Text] [Related]
7. The roles of orphan nuclear receptors in the development and function of the immune system.
Dzhagalov I; Zhang N; He YW
Cell Mol Immunol; 2004 Dec; 1(6):401-7. PubMed ID: 16293208
[TBL] [Abstract][Full Text] [Related]
8. The gene encoding fibrinogen-beta is a target for retinoic acid receptor-related orphan receptor alpha.
Chauvet C; Bois-Joyeux B; Fontaine C; Gervois P; Bernard MA; Staels B; Danan JL
Mol Endocrinol; 2005 Oct; 19(10):2517-26. PubMed ID: 15941850
[TBL] [Abstract][Full Text] [Related]
9. Enhanced endocrine response to novel environment stress and lack of corticosterone circadian rhythm in staggerer (Rora sg/sg) mutant mice.
Frédéric F; Chianale C; Oliver C; Mariani J
J Neurosci Res; 2006 Jun; 83(8):1525-32. PubMed ID: 16555296
[TBL] [Abstract][Full Text] [Related]
10. A role of the bile salt receptor FXR in atherosclerosis.
Hageman J; Herrema H; Groen AK; Kuipers F
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1519-28. PubMed ID: 20631352
[TBL] [Abstract][Full Text] [Related]
11. RORalpha regulates the expression of genes involved in lipid homeostasis in skeletal muscle cells: caveolin-3 and CPT-1 are direct targets of ROR.
Lau P; Nixon SJ; Parton RG; Muscat GE
J Biol Chem; 2004 Aug; 279(35):36828-40. PubMed ID: 15199055
[TBL] [Abstract][Full Text] [Related]
12. Retinoid-related orphan receptor gamma regulates several genes that control metabolism in skeletal muscle cells: links to modulation of reactive oxygen species production.
Raichur S; Lau P; Staels B; Muscat GE
J Mol Endocrinol; 2007 Jul; 39(1):29-44. PubMed ID: 17601883
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation of RORalpha potentiates transcriptional activation function.
Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
[TBL] [Abstract][Full Text] [Related]
14. Overexpression, refolding, and purification of polyhistidine-tagged human retinoic acid related orphan receptor RORalpha4.
Lechtken A; Zündorf I; Dingermann T; Firla B; Steinhilber D
Protein Expr Purif; 2006 Sep; 49(1):114-20. PubMed ID: 16682227
[TBL] [Abstract][Full Text] [Related]
15. Identification of the RORα Transcriptional Network Contributes to the Search for Therapeutic Targets in Atherosclerosis.
Matsuoka H; Michihara A
Biol Pharm Bull; 2021; 44(11):1607-1616. PubMed ID: 34719639
[TBL] [Abstract][Full Text] [Related]
16. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
17. Identification of the human ApoAV gene as a novel RORalpha target gene.
Lind U; Nilsson T; McPheat J; Strömstedt PE; Bamberg K; Balendran C; Kang D
Biochem Biophys Res Commun; 2005 Apr; 330(1):233-41. PubMed ID: 15781255
[TBL] [Abstract][Full Text] [Related]
18. Melatonin and type 2 diabetes - a possible link?
Peschke E; Stumpf I; Bazwinsky I; Litvak L; Dralle H; Mühlbauer E
J Pineal Res; 2007 Apr; 42(4):350-8. PubMed ID: 17439551
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of adipocyte differentiation by RORalpha.
Duez H; Duhem C; Laitinen S; Patole PS; Abdelkarim M; Bois-Joyeux B; Danan JL; Staels B
FEBS Lett; 2009 Jun; 583(12):2031-6. PubMed ID: 19450581
[TBL] [Abstract][Full Text] [Related]
20. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
Kontush A; Chapman MJ
Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
